Brand
IMAXEN 100 mg
Tablet
- Generic (active ingredient)
- ImatinibThe medicine's active ingredient, shared by many brands.
- Manufacturer
- Everest Pharmaceuticals Ltd.
Price comparison
Price information coming soon.
We only show prices from a verified source, and none is available for this medicine yet. Prices and availability vary by pharmacy.
Browse pharmacies (listings only, without prices).
Medicine information & safety
Detailed side-effect and safety information isn't available for this medicine yet
We only publish this information when it comes from a cited source we are allowed to use. The reference below is run by someone else and does not depend on us.
External references
Opens an external site. US labels can differ from products registered in Bangladesh.
This information is for general education and does not replace advice from a qualified healthcare professional.
Other products containing the same generic
8 other registered brands with the same generic, strength and form (Imatinib 100 mg tablet). Products with the same generic may differ in inactive ingredients, manufacturer and registration. This list is for information only and is not a recommendation to substitute one product for another.
Other strengths and forms
Imatinib in a different strength or dosage form. These are not interchangeable without professional advice.
Product details
- Brand name
- IMAXEN
- Registered name
- IMAXEN 100
- Generic name
- Imatinib
- Strength
- 100 mg
- Dosage form
- Tablet
- Manufacturer
- Everest Pharmaceuticals Ltd.
- DGDA registration (DAR) no.
- 157-0191-010
Source: DGDA Registered Drug Products (Directorate General of Drug Administration (DGDA), via DGHS national terminology server), retrieved 4 Oct 2026. Registration data shows the product is registered in Bangladesh; it does not confirm current availability.
Frequently asked questions
What is the generic name of IMAXEN 100 mg?
Who makes IMAXEN 100 mg?
Is something incorrect?
Report this information
Reporting is not set up yet, so nothing can be sent from here.